Search Results 541-550 of 3126 for 百度搜索留痕咨询邮箱：lgooxc@hotmail.com

  1. Breast cancer - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  2. Heart Failure Patients Ventilatory Constraint During Exercise - Mayo Clinic

    The purpose of this study is to characterize the ventilatory response to exercise in females with HFrEF and determine if mechanical ventilatory constraint ...

  3. Benefits - Center for Clinical and Translational Science

    The CCaTS Office of Translation to Practice offers multiple benefits to Mayo Clinic individual researchers and collaborators.

  4. A Study to Evaluate the Effectiveness and Safety of Pemigatinib in Previously-treated, Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207) - Mayo Clinic

    A Study to Evaluate the Effectiveness and Safety of Pemigatinib in Previously-treated, Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor ...

  5. Breast cancer - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  6. Clinical Trials - Evaluating Tele-Ichthyosis

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered via Transendocardial Catheter-based Injections to Subjects with Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) - Mayo Clinic

    An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered via Transendocardial Catheter-based Injections to Subjects with Heart Failure Due to ...

  8. Publications - Yi Lin, M.D., Ph.D. - Mayo Clinic

    Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma. Blood Cancer J. 2024 Oct 16; 14(1):180.

  9. A Study to Evaluate the Safety and Effectiveness of SAR442168 Compared to Placebo in Primary Progressive Multiple Sclerosis (PPMS) Patients - Mayo Clinic

    The primary objectgive of this study is to determine the effectiveness of SAR442168 compared to placebo in delaying disability progression in primary ...

  10. Assess the Long-term Safety and Effecticeness of Osilodrostat in Patients with Endogenous Cushing’s Syndrome - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...